Aprosencephaly cerebellar dysgenesis

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1126OMIM:601374Q04.3
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Aprosencephaly with cerebellar dysgenesis is an extremely rare and severe congenital brain malformation characterized by the near-complete absence of the forebrain (prosencephalon) combined with abnormal development of the cerebellum. This condition represents one of the most severe forms of brain maldevelopment, considered even more severe than alobar holoprosencephaly. Affected infants typically present with profound neurological impairment, absence of recognizable cerebral hemispheres, and significant cerebellar abnormalities. Craniofacial anomalies are commonly associated, including microcephaly, facial dysmorphism, and features overlapping with the holoprosencephaly spectrum such as cyclopia, proboscis, or other midline facial defects. The condition affects the central nervous system primarily, with devastating consequences for brain structure and function. Key clinical features include severe intellectual disability, absence of voluntary movement, seizures, and failure to thrive. Affected neonates typically have a very poor prognosis, with most cases being lethal in the neonatal period or early infancy. Additional malformations involving other organ systems, including the eyes and skeletal system, may also be present. There is currently no curative treatment for aprosencephaly with cerebellar dysgenesis. Management is supportive and palliative, focusing on comfort care and addressing immediate medical needs such as feeding difficulties and seizure management. Genetic counseling is recommended for affected families. Some cases have been reported in siblings, suggesting a possible autosomal recessive inheritance pattern, though the genetic basis remains incompletely understood.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Aprosencephaly cerebellar dysgenesis.

View clinical trials →

No actively recruiting trials found for Aprosencephaly cerebellar dysgenesis at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Aprosencephaly cerebellar dysgenesis community →

No specialists are currently listed for Aprosencephaly cerebellar dysgenesis.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Aprosencephaly cerebellar dysgenesis.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Aprosencephaly cerebellar dysgenesisForum →

No community posts yet. Be the first to share your experience with Aprosencephaly cerebellar dysgenesis.

Start the conversation →

Latest news about Aprosencephaly cerebellar dysgenesis

No recent news articles for Aprosencephaly cerebellar dysgenesis.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Aprosencephaly cerebellar dysgenesis

What is Aprosencephaly cerebellar dysgenesis?

Aprosencephaly with cerebellar dysgenesis is an extremely rare and severe congenital brain malformation characterized by the near-complete absence of the forebrain (prosencephalon) combined with abnormal development of the cerebellum. This condition represents one of the most severe forms of brain maldevelopment, considered even more severe than alobar holoprosencephaly. Affected infants typically present with profound neurological impairment, absence of recognizable cerebral hemispheres, and significant cerebellar abnormalities. Craniofacial anomalies are commonly associated, including microc

How is Aprosencephaly cerebellar dysgenesis inherited?

Aprosencephaly cerebellar dysgenesis follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Aprosencephaly cerebellar dysgenesis typically begin?

Typical onset of Aprosencephaly cerebellar dysgenesis is neonatal. Age of onset can vary across affected individuals.